Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to look through drug repositioning practices and exploitation of available scientific evidence for potential efficient drugs...
Saved in:
Main Authors: | Marios Spanakis, Athina Patelarou, Evridiki Patelarou, Nikolaos Tzanakis |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c8e11f03c1724e42be50bdc78ade76c4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience
by: Beril Kara Esen, et al.
Published: (2021) -
Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models
by: Stevenson JM, et al.
Published: (2014) -
The war on COVID-19 and vaccination mandates: Ethical code of conduct
by: Norma Visagie
Published: (2021) -
Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018) -
Workforce
Published: (1997)